These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22772338)

  • 21. Assessment of mitotic rate reporting in melanoma.
    Burton AL; Egger ME; Gilbert JE; Stromberg AJ; Hagendoorn L; Martin RC; Scoggins CR; McMasters KM; Callender GG
    Am J Surg; 2012 Dec; 204(6):969-74; discussion 974-5. PubMed ID: 23036603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The magic of numbers: malignant melanoma between science and pseudoscience.
    Weyers W
    Am J Dermatopathol; 2011 Jun; 33(4):371-8. PubMed ID: 21478727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of thorough block sampling in the histologic evaluation of melanomas.
    Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
    Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
    Gimotty PA; Botbyl J; Soong SJ; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.
    Corona R; Mele A; Amini M; De Rosa G; Coppola G; Piccardi P; Fucci M; Pasquini P; Faraggiana T
    J Clin Oncol; 1996 Apr; 14(4):1218-23. PubMed ID: 8648377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-observer variation in the histopathology reports of head and neck melanoma; a comparison between the seventh and eighth edition of the AJCC staging system.
    Berger DMS; Wassenberg RM; Jóźwiak K; van de Wiel BA; Balm AJM; van den Berg JG; Klop WMC
    Eur J Surg Oncol; 2019 Feb; 45(2):235-241. PubMed ID: 30385156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma pathology reporting and staging.
    Scolyer RA; Rawson RV; Gershenwald JE; Ferguson PM; Prieto VG
    Mod Pathol; 2020 Jan; 33(Suppl 1):15-24. PubMed ID: 31758078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia.
    Heenan PJ; Matz LR; Blackwell JB; Kelsall GR; Singh A; ten Seldam RE; Holman CD
    Histopathology; 1984 Sep; 8(5):717-29. PubMed ID: 6519646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of histopathological reporting on melanoma and influence of use of a synoptic template.
    Haydu LE; Holt PE; Karim RZ; Madronio CM; Thompson JF; Armstrong BK; Scolyer RA
    Histopathology; 2010 May; 56(6):768-74. PubMed ID: 20546342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic study of recurrent Clark level II melanomas.
    Glass LF; Guffey JM; Schroer KR; Reintgen D
    Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL; Fine JA; Roush GC; Berwick M
    Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
    Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
    Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Histopathological prognostic factors of malignant melanoma].
    Plótár V; Orosz Z; Tóth E; Szentirmay Z
    Magy Onkol; 2007; 51(1):39-46. PubMed ID: 17417674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.